Featured News

Traveling gluten-free can be a great way to explore foreign cuisines and sample foods from around the globe that you otherwise might never try. Although it may take some time…

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled "Celiac Disease: On the Horizon". Registration open now.

The FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

Anokion SA released successful results from their Phase 1 ACeD clinical trial and they will be moving forward with Phase 2 trials later this year.

Celiac Disease Foundation Chief Executive, Marilyn G. Geller, was recently interviewed by The Waiting Room, a patient information website, to highlight the work and accomplishments of the Foundation.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

ZED1227, an experimental drug was found to be able to prevent intestinal damage in a preliminary trial of 163 adults with celiac disease.

Ukko, a startup focused on eradicating food allergies, intolerances, and sensitivities, has reached a promising stage in its effort to develop a gluten specifically designed for people with celiac disease.